Know What's Happening in BioTech
Know What's Happening in BioTech
BioTech Pulse
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
An international team led by the University of Edinburgh created a comprehensive functional map of 342 possible missense mutations in the CTNNB1 hotspot, assigning activity scores to over 80% of cancer‑observed variants. Using mouse stem cells and genome‑editing, they measured how each change alters β‑catenin signaling. The data reveal a spectrum from weak to strong pathway activation, with stronger mutations linked to immune‑cold hepatocellular carcinoma and weaker ones to immune‑rich tumors. The map offers a predictive tool for variant classification and personalized therapy design.
Sinorda Biomedicine has teamed with WuXi Biologics to develop and manufacture SND006, a bispecific antibody aimed at treating inflammatory bowel disease and other autoimmune conditions. The partnership leverages WuXi’s extensive biologics expertise to accelerate preclinical pharmacology, clinical‑supply manufacturing, and IND...
University of Missouri engineer Susie Dai has genetically engineered algae that secrete limonene, rendering them water‑repellent and capable of aggregating microplastics into sinkable clumps. The algae simultaneously consume excess nutrients, allowing the combined biomass‑plastic aggregates to be harvested from wastewater....
Researchers have unveiled a novel synthetic compound that dramatically reduces malaria parasite levels in animal models and simultaneously blocks transmission to mosquitoes. In pre‑clinical trials, the molecule achieved over 90% clearance of blood‑stage parasites and a 95% reduction in gametocyte...
An open‑access review links regular exercise to enhanced DNA‑repair pathways that may decelerate muscle aging. It outlines two emerging mechanisms: somatic mosaicism from stem‑cell mutations and epigenetic drift driven by repeated double‑strand break repair. The paper highlights how chronic training...
Novo Nordisk disclosed Phase III data showing its next‑generation metabolic therapy CagriSema outperformed the GLP‑1 blockbuster semaglutide in type 2 diabetes. The trial reported larger reductions in HbA1c and greater body‑weight loss while maintaining a comparable safety profile. CagriSema’s superiority was observed...
Wave Life Sciences will continue developing its RNA‑editing candidate WVE‑006 for alpha‑1 antitrypsin deficiency (AATD) after GSK relinquished its stake, aiming for accelerated regulatory feedback by mid‑2026. The AATD market, valued at $2.6 billion today, is projected to reach $6.2 billion by...
Fraunhofer’s Center for Sensor Intelligence has unveiled the Multimodal Autonomous Sensor Platform (MAUS), an intelligent sensor suite that continuously monitors 3D cell‑spheroid production in bioreactors. The system combines electrochemical probes for glucose, lactate, dissolved oxygen, pH and temperature with dual‑camera...
Novo Nordisk announced Phase 3 results for its combination injection CagriSema, showing superior glycemic control and greater weight loss than Wegovy in patients with type 2 diabetes and obesity. In the 68‑week trial of more than 2,700 participants, CagriSema lowered HbA1c by...
Researchers discovered that silencing Wnt Inhibitory Factor 1 (WIF1) markedly boosts angiogenic activity in human umbilical vein endothelial cells exposed to hypoxic stress. The inhibition lifts repression on the Wnt pathway, leading to elevated VEGF and other pro‑angiogenic markers. In‑vitro experiments...
A new neuroimaging study shows that infants as young as six months possess a richly organized ventrotemporal cortex capable of distinguishing visual categories such as faces, objects, and scenes. Functional MRI scans revealed distinct, adult‑like activation patterns for each category,...
Sanofi was found to have breached the UK pharmaceutical code after its chief executive, Paul Hudson, made unbalanced statements in an Observer interview comparing the company’s RSV antibody Beyfortus with Pfizer’s vaccine Abrysvo. The Prescription Medicines Code of Practice Authority...
Federal agents and local police raided a Las Vegas residence suspected of housing a clandestine biological laboratory, uncovering refrigerators filled with vials of unknown liquids. The operation is tied to a broader, multi‑agency investigation that may connect the site to...
A recent multi-center study shows that opportunistic salpingectomy, performed during routine benign gynecologic surgeries, reduces the risk of tubo‑ovarian carcinoma by nearly 80 percent. The analysis, spanning over 15,000 women and a median follow‑up of 12 years, found no increase...
Researchers have identified a set of broadly neutralizing antibodies that target the conserved glycoprotein B (gB) of gammaherpesviruses. The antibodies bind multiple viral strains, blocking entry in cell culture and reducing viral load in mouse models. Structural analysis revealed a...
Researchers have mapped the gonadal transcriptome across key developmental stages of the Siberian sturgeon, a species prized for caviar and aquaculture. Using high‑throughput RNA sequencing, they identified stage‑specific gene expression patterns governing sex differentiation, gametogenesis, and hormonal regulation. The dataset...
The European Medicines Agency has issued a recommendation for conditional marketing authorization of Sanofi Winthrop’s Rezurock (belumosudil) to treat chronic graft‑versus‑host disease in patients aged 12 and older. In an open‑label study, 73% of participants achieved a response, with 44%...
Death Clock has introduced Life Lab, an AI‑driven health concierge that combines lab testing, medical records, and longevity research to move care from reactive treatment to proactive prevention. The platform partners with more than 4,800 Labcorp, Quest and BioReference locations,...
GlaxoSmithKline has terminated its collaboration with Wave Life Sciences, returning all rights to the RNA‑editing program aimed at treating alpha‑1 antitrypsin deficiency (AATD). The decision ends a partnership that was closely watched as a potential first‑in‑class RNA‑editing therapy. GSK will...
Recent disclosures illustrate how multimeric design is reshaping drug discovery in the beyond‑Rule‑of‑5 (bRo5) space. GSK’s dimeric BET inhibitor GSK785 uses a rigid diazaspiro linker to achieve >30‑fold BRD4 selectivity, while Eli Lilly’s muvalaplin dimer‑to‑trimer architecture delivers a 10,000‑fold potency boost...
The U.S. Food and Drug Administration issued a complete response letter to Aquestive Therapeutics, rejecting its allergy medication because of packaging deficiencies. The agency identified labeling and child‑resistance failures that do not meet federal standards. As a result, the drug’s...
PolyAseqTrap: a universal tool for genome-wide identification and quantification of polyadenylation sites from different 3′ end sequencing data https://t.co/pwEf2GeYjb github https://t.co/gpfYhyMoX3 https://t.co/oyA5MBFutE
Researchers engineered palladium‑integrated indium oxide with abundant structural defects to create a high‑performance sonocatalyst for hepatocellular carcinoma. The Pd component provides catalase‑like and peroxidase‑like activities, relieving tumor hypoxia and increasing hydroxyl‑radical generation under ultrasound. This dual action triggers a synergistic...
Researchers employed an AI‑guided workflow to engineer pH‑ and redox‑responsive Lignin@GO@ZIF‑8 nanocarriers that co‑deliver 5‑fluorouracil and metformin for prostate cancer treatment. Machine‑learning models, particularly XGBoost trained on 500 formulation data points, achieved R² values of 0.86‑0.89 for predicting drug loading,...
The U.S. Food and Drug Administration has opened the first round of submissions for its new PreCheck program, designed to accelerate the construction and approval of drug manufacturing facilities. By allowing manufacturers to submit detailed construction plans early, the initiative...
1/ Many bioinformatics students don’t know much about NGS pre-processing. But trust me, understanding the raw data is essential. Here’s why. https://t.co/WjT1I9haD8
Researchers at Diamond Light Source and the University of Oxford introduced xSAR, a quantitative crystallographic SAR approach that converts fragments into Morgan fingerprint bits to calculate Positive and Negative Binding Scores (PBS/NBS). Applying PBS to 957 crude‑reaction fragments recovered 23...
Researchers have introduced an enhanced voting strategy to classify nutrient profiles in date palm crops more accurately. The ensemble approach merges spectral imaging, chemical assays, and machine‑learning classifiers, lifting overall accuracy to roughly 94 percent. Validation across multiple orchards showed...
ConcertAI unveiled Accelerated Clinical Trials (ACT), an enterprise platform powered by its CARAai agentic AI, to automate end‑to‑end trial processes. The solution claims to shorten overall trial timelines by 10‑20 months and cut design and amendment costs by roughly half....
GSK has returned Wave Life Sciences' RNA‑editing oligonucleotide WVE‑006 after a modest Phase Ib/IIa readout for alpha‑1 antitrypsin deficiency. The September data showed 11.9 µM AAT, slightly below analyst expectations, prompting GSK to refocus on larger indications like COPD. Despite the...
5 more dairy cows tested positive for #H5N1 #birdflu antibodies on the Dutch farm where a previous cow tested positive. No surprise that if 1 was positive, others would be too. This dairy farm is the first outside the US...
The U.S. Supreme Court has agreed to hear Amarin Pharma’s claim that Hikma Pharmaceuticals’ skinny‑label generic of Vascepa induces infringement of Amarin’s patented cardiovascular indication. The dispute centers on whether generic marketing that references the branded drug’s market size can...
The blog post emphasizes dose as a pivotal factor distinguishing first‑in‑class from next‑generation therapeutics. It links total dose and dosing regimen to core drug attributes such as potency, pharmacokinetics, and safety. The discussion covers route of administration, dosing schedules, and...
A recent narrative review by Dr. J.N. Allan evaluates fixed‑duration (FD) regimens in chronic lymphocytic leukemia, contrasting them with traditional indefinite therapies. Early clinical data show that FD schedules can achieve deep remissions while reducing side‑effects and treatment time. However,...
Researchers have demonstrated that next‑generation mRNA vaccines can neutralize the haemozoin barrier that malaria parasites use to evade host immunity. Preclinical trials in murine models showed a 78% reduction in parasitemia compared with conventional protein subunit vaccines. The mRNA platform...
The FDA issued a complete response letter rejecting Corcept Therapeutics' relacorilant for hypercortisolism, citing significant review issues identified early in the submission process. While the Phase III GRACE trial met its primary endpoint, the agency questioned the hypertension data and warned...
A new study by Tang, Guo and Zhang applies network toxicology and molecular dynamics to map how the plasticizer DEHP and its metabolite MEHP interact with immune‑related proteins. The research identifies specific molecular pathways that link DEHP exposure to the...
Researchers have unveiled AI-driven models that accurately predict and redesign protospacer adjacent motif (PAM) sequences for a wide range of CRISPR‑Cas enzymes. The platform leverages deep learning on millions of natural and synthetic PAM datasets, achieving up to 40% reduction...
The U.S. Food and Drug Administration issued a complete response letter rejecting Pharming's request to extend Joenja (leniolisib) to children aged four to 11 with activated phosphoinositide 3‑kinase delta syndrome (APDS). The agency flagged potential under‑exposure in lower‑weight pediatric patients...
PharmTech interviewed Katy MacLellan, Technical Team Leader at Symbiosis, about her journey from a Scottish island to senior roles at Pfizer, Eli Lilly, CSL Seqirus and now Symbiosis. She highlights how female mentorship and visible STEM programs propelled her career and how companies...
Sanofi announced that its oral glucosylceramide synthase inhibitor venglustat achieved statistically significant neurological improvements in a Phase 3 trial for type 3 Gaucher disease, prompting regulatory filing plans. The same drug failed to demonstrate efficacy in a Fabry disease study, adding to...
Sanofi’s substrate‑reduction therapy venglustat met its primary endpoint in a Phase 3 trial for type 1 Gaucher disease, showing statistically significant reductions in glucosylceramide levels and improved organ volumes. The study enrolled 400 patients across North America and Europe and demonstrated a...
BIO submitted a statement to the House Ways & Means Trade Subcommittee urging Congress to adopt policies that preserve U.S. biotech leadership. The organization highlighted the sector’s explosive growth, projecting a $4.25 trillion global market by 2033, and called for expanded...
Researchers have performed a genome‑wide survey of GATA transcription factors in major cucurbit crops, including cucumber, melon, watermelon, pumpkin, and squash. The study identified 30 GATA genes and mapped their chromosomal locations, revealing conserved zinc‑finger domains typical of the family....
Researchers analyzed small non‑coding RNAs in participants of the CALERIE Phase 2 calorie‑restriction trial, which achieved a 12‑15% reduction in intake over 12‑24 months. Using smRNA sequencing of plasma, muscle, and adipose tissue, they identified 16 RNAs linked to the degree of...
The FDA has opened its PreCheck pilot, a two‑phase program designed to speed regulatory approval for new pharmaceutical manufacturing sites in the United States. The agency will select facilities this year based on national‑priority products, development stage, and timeline to...
A recent mouse study shows that aging dramatically reshapes the peripheral γδ T‑cell compartment, expanding innate‑like subsets that produce higher levels of IL‑17. The age‑associated shift coincides with a marked loss of the transcription factor Foxo1 within these cells. Researchers...
UCB’s Kygevi (doxecitine and doxribtimine) received a CHMP recommendation for EU approval, targeting thymidine kinase 2 deficiency (TK2d) in patients whose disease began before age 12. The drug already secured FDA approval last November and is slated for launch in the...
Researchers applied single-cell omics to dissect lymph‑node metastasis in solid tumors, revealing distinct cellular subpopulations that drive spread. The study identified a set of mutation‑linked gene signatures that correlate with aggressive dissemination and uncovered novel surface markers for early detection....
A recent multi‑institutional study compared 3D‑printed cricothyrotomy simulators with conventional mannequin models. Participants using the 3D devices completed the airway access procedure 15% faster and demonstrated higher tactile realism. The research also highlighted a 40% reduction in per‑unit cost for...
